Suresh Kumar Nayudu

Director/Associate Professor of Clinical Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Suresh Kumar Nayudu is the Director and Associate Professor of Clinical Medicine at SBH Health System in the United States. His research primarily focuses on clinical outcomes related to gastrointestinal conditions and the impact of obesity and infections on patient health, particularly in vulnerable populations. Recent articles authored by Dr. Nayudu explore topics such as nonvariceal upper gastrointestinal bleeding, endoscopic drainage for pancreatic pseudocysts, and the association of body mass index with COVID-19 outcomes.

Articles (11)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Michel Kahaleh

Robert Wood Johnson University Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Suresh Kumar Nayudu

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Clinical outcomes of nonvariceal upper gastrointestinal bleeding in nonagenarians and octogenarians: a comparative nationwide analysis

Increasing trend of endoscopic drainage utilization for the management of pancreatic pseudocyst: insights from a nationwide database

Cachexia and Invisible Stomach on Endoscopy: An Endoscopist’s Enigma and a Surgeon’s Axiom

Role of body mass index in outcomes of patients hospitalized with COVID‐19 illness

Patients with Clostridium difficile infection and prior appendectomy may be prone to worse outcomes

The Incidence and Mortality Impact of Gastrointestinal Bleeding in Hospitalized COVID-19 Patients

Implementation and outcomes of monoclonal antibody infusion for COVID-19 in an inner-city safety net hospital: A South-Bronx experience

Clostridioides difficile Infection and Liver Cirrhosis – A Retrospective, Cohort Study

Fr008 THE CLINICAL SIGNIFICANCE OF ELEVATED LIPASE LEVELS IN COVID-19 PATIENTS - A LARGE RETROSPECTIVE COHORT STUDY

Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19

Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study

Collaborators (1)

Michel Kahaleh

Make your next move.